[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"greater-trochanteric-pain-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:greater-trochanteric-pain-syndrome":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,48,75,135,163,191],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100636617","reneurx-nerve-selective-therapy-utilized-in-lateral-hip-pain-100636617",false,"NCT07568015","ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain","ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain: A Multi-Center, Randomized, Controlled Trial (RENEU)","RENEU","Inclusion Criteria:\n\n1. Age 22 to 80, inclusive of any gender\n2. Baseline pain intensity of \\>5 of the Numeric Rating Scale (NRS) localized to the lateral aspect of the hip (with or without radiation to lateral thigh or buttock) despite current treatment\n3. Tenderness to palpation of the peritrochanteric space of the lateral hip in adults with Greater Trochanteric Pain Syndrome.\n4. At least 6 months of previous conservative treatments for subject's lateral hip pain (NSAID, acetaminophen, physical therapy, and\u002For cortisone injections) that are not currently providing relief\n5. Agree to see study investigator and study team for hip pain during the study period\n6. Willing\u002Fable to understand the informed consent form and provide written informed consent\n7. Able to complete outcome measures (including electronic patient reported outcome measures)\n\nExclusion Criteria:\n\n1. Known allergy to glycerol, hyaluronic acid, poloxamer 407, or phosphate buffered saline\n2. History of cryoglobulinemia\n3. History of cold-induced auto-immune hemolytic anemia (e.g. paroxysmal cold hemoglobinuria or cold agglutinin disease)\n4. History of cold urticaria\n5. History of Chilblain's (pernio) disease in the lower extremities\n6. History of Raynaud's disease\n7. Open and\u002For infected wounds or active tumor at or near the treatment site\n8. History of vascular surgery involving femoral vessels on theinjection side\n9. History of hip surgery of any kind to the index side within the past 6 months (e.g., arthroscopy, arthroplasty, etc.)\n10. History of trochanteric osteotomy, femoral osteotomy, or amputation\n11. Active bacterial or fungal infection that, at the discretion of the investigator, would preclude study participation\n12. Currently taking \\>60 MME\u002Fday\n13. History of systemic inflammatory conditions such as rheumatoid arthritis\n14. Bleeding disorders, unless appropriately stopped or reversed for the procedure at investigator's discretion\n15. Any neuropathic pain condition (e.g. - complex regional pain syndrome, lumbar radiculopathy) in the area of pain\n16. Presence of unstable psychiatric disease\n17. Cryoneurolysis, thermal or pulsed radiofrequency ablation, or phenol injection for the index hip(s) within the past 12 months\n18. Corticosteroid injection within the previous 3 months or orthobiologic therapy such as platelet rich plasma injections for the index hip(s) within the previous 6 months\n19. Known contraindication to use of a regional anesthetic block\n20. Pregnant, nursing, or intent of becoming pregnant during the study period\n21. Documented evidence of an overlapping pain pattern from another source that the Investigator believes to be indistinguishable from lateral hip pain\n22. Lumbar or sacroiliac fusion within the previous 6 months\n23. Any other condition (such as history of deep vein thrombosis, significant cardiovascular, renal failure\u002Fdialysis, hepatic or other systemic comorbidity\u002Fchronic pain condition including cancer) or circumstance that, in the opinion of the investigator, would compromise the safety of the subject or the quality of study data\n24. Body habitus\u002Fhip anatomy that would preclude the use of the product injection needle size\n25. Participation in any clinical study of a therapeutic investigational product within 30 days prior to enrollment\n26. Pending litigation or disability status\n27. Unwilling to refrain from any scheduled surgeries that would impact the collection of study endpoint data during the duration of the study\n28. Subject is a prisoner","ALL","22 Years","80 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.",[28,29,30],"Greater Trochanteric Pain Syndrome","Greater Trochanteric Pain Syndrome of Both Lower Limbs","Lateral Hip Pain",[15,32,33,34],"ReneuRx™","ReneuRx","GTPS","NOT_YET_RECRUITING","2026-06-24",{"date":38,"type":39},"2026-06-29","ACTUAL",{"date":41,"type":22},"2026-07-01",{"date":43,"type":22},"2029-11-01",{"name":45,"class":46},"Brixton Biosciences, Inc.","INDUSTRY",11,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":23,"phases":60,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":74},"100493858","evaluation-of-tenex-for-greater-trochanteric-pain-syndrome-gtps-100493858","NCT05710627","Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)","Evaluation of Percutaneous Tenotomy of the Gluteus Medius and Iliotibial Band for Greater Trochanteric Pain Syndrome (GTPS): A Randomized Clinical Trial","RCT GTPS","Inclusion Criteria:\n\n* Aged 18-90\n* People with GTPS of all different levels and etiologies confirmed with MRI or CT scan\n* Ability to give informed consent forms independently\n* Failed conservative medical treatment for at least 6 months\n\nExclusion Criteria:\n\n* Significant mobility restrictions; people using wheelchairs\n* Pregnancy\n* Previous surgery to the GMed or ITB","30 Years","90 Years",{"count":59,"type":22},150,[25],"The objective of this study is to evaluate how an ultrasound-guided percutaneous procedure, TENEX, can help people with chronic hip pain resulting from a condition called Greater Trochanteric Pain Syndrome (GTPS) and to characterize the efficacy of percutaneous tenotomy (PUT) using TENEX®, a device used for the treatment of various tendinopathies. In this study an ultrasound (US) is performed to guide the partial release of gluteus medius and minimus and Iliotibial band tendons in patients diagnosed with refractory Greater Trochanteric Pain Syndrome (GTPS) vs control. The investigator team hypothesizes that the new TENEX can improve the pain level for individuals with GTPS to help those individuals perform their activities of daily living (ADLs), e.g., walking, standing, and side-lying, as well as demonstrate less medication utilization. The study predicts that this percutaneous outpatient procedure can decrease pain, increase mobility, and decrease medication utilization.\n\nThe study team hypothesizes that PUT can improve the pain level and function for individuals suffering with GTPS. The study will assess walking, standing, and side-lying tolerance, as well as medication utilization. The investigator team predicts that this percutaneous outpatient procedure can decrease pain and medication utilization while increasing mobility.",[28],"RECRUITING","2026-05-05",{"date":66,"type":39},"2026-05-08",{"date":68,"type":39},"2025-03-11",{"date":70,"type":22},"2028-12",{"name":72,"class":73},"Montefiore Medical Center","OTHER",1,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":23,"phases":83,"briefSummary":85,"conditions":86,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":4},"100611443","phase-4-outcomes-from-hyperbaric-oxygen-hbo2-treatment-for-emerging-indications-100611443","NCT07240649","Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications","Emerging Indications for Hyperbaric Oxygen Treatment","Inclusion Criteria:\n\n* Patients referred for HBOT with an emerging indication\n\nExclusion Criteria:\n\n* Contraindication to hyperbaric oxygen treatment (untreated seizures, pneumothorax, significant pulmonary airspace pathology that might lead to pulmonary barotrauma, unmanageable confinement anxiety, chronic obstructive pulmonary disease with CO2 retention)\n* Pregnant persons",{"count":21,"type":22},[84],"PHASE4","This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.",[87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,28,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126],"Post-COVID-19 Condition","Ulcerative Colitis","Crohn Disease","Calciphylaxis","Frostbite","Acute COVID-19","Pyoderma Gangrenosum","Pterygium","Hypospadias","Head Trauma","Pneumatosis Intestinalis","Ischemic Bowel","Raynaud Syndrome","Malignant Otitis Externa","Nonarteritic Anterior Ischemic Optic Neuropathy","Central Retinal Vein Occlusion","Femoral Head Necrosis","Invasive Fungal Infection","Chronic Anal Fissure","Vasculitic Ulcer","Graft-vs-Host Disease","Decubitus Ulcer","Rectovaginal Fistula","Pouchitis","Tinnitus","Clostridium Enterocolitis","Branch Retinal Artery Occlusion","Axonotmesis","Multiple Sclerosis","Inclusion Body Myositis","Epidermolysis Bullosa (EB)","Osteonecrosis","Ulcer Ischemic","Avascular Necrosis of Bone","Prosthesis Related Infections","Facial Filler Injections","Cystitis Chronic","Ligament Injury","Anastomosis, Leaking","Cartilage Injury","2026-05-01",{"date":64,"type":39},{"date":130,"type":22},"2026-08",{"date":132,"type":22},"2035-12",{"name":134,"class":73},"Jay C. Buckey Jr.",{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":4,"eligibilityCriteria":141,"healthyVolunteers":11,"sex":17,"minAge":142,"maxAge":143,"enrollmentInfo":144,"targetDuration":4,"studyType":23,"phases":146,"briefSummary":147,"conditions":148,"keywords":149,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":157,"completionDateStruct":159,"leadSponsor":161,"locationsCount":74},"100611649","eswt-vs-conventional-physical-therapy-in-greater-trochanteric-pain-syndrome-100611649","NCT07243327","ESWT vs Conventional Physical Therapy in Greater Trochanteric Pain Syndrome","A Prospective Randomized Controlled Trial Comparing the Effectiveness of Extracorporeal Shockwave Therapy and Conventional Physical Therapy in Patients With Greater Trochanteric Pain Syndrome","Inclusion Criteria:\n\n* Age between 18 and 65 years\n* Lateral hip pain for at least 3 months\n* Ability to understand study procedures and provide informed consent\n\nExclusion Criteria:\n\n* Hip deformities\n* Gluteus medius, gluteus minimus, or piriformis tendon tears\n* Lumbar radiculopathy or history of lumbar spine surgery\n* Recent trauma or active infection in the hip region\n* Corticosteroid injection to the hip within the last 6 months\n* Neurological, psychiatric, or rheumatologic diseases\n* Active malignancy or systemic inflammatory disease\n* Cognitive impairment preventing cooperation","18 Years","65 Years",{"count":145,"type":22},60,[25],"This study aims to compare the effectiveness of Extracorporeal Shockwave Therapy (ESWT) with conventional physical therapy in patients with Greater Trochanteric Pain Syndrome (GTPS). GTPS is a common cause of lateral hip pain, often related to gluteal tendinopathy rather than trochanteric bursitis. Sixty patients will be randomly assigned to two groups: ESWT or conventional physical therapy (TENS, hot pack, ultrasound). Pain (VAS), hip function (Harris Hip Score), lower limb function (LEFS), and global improvement will be evaluated at baseline, week 3, and week 12. The purpose of this study is to determine which treatment provides greater pain relief and functional improvement.",[28],[150,151,152,153],"Extracorporeal shockwave therapy","Physical therapy","Hip pain","ESWT","2026-01-24",{"date":156,"type":39},"2026-01-27",{"date":158,"type":39},"2025-12-01",{"date":160,"type":22},"2026-03",{"name":162,"class":73},"Kanuni Sultan Suleyman Training and Research Hospital",{"id":164,"slug":165,"hasResults":11,"nctId":166,"briefTitle":167,"officialTitle":168,"acronym":4,"eligibilityCriteria":169,"healthyVolunteers":11,"sex":17,"minAge":142,"maxAge":170,"enrollmentInfo":171,"targetDuration":4,"studyType":23,"phases":172,"briefSummary":173,"conditions":174,"keywords":178,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":182,"lastUpdatePostDateStruct":183,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":74},"100548224","exercise-and-patient-education-for-patients-with-lateral-hip-pain-100548224","NCT06418217","Exercise and Patient Education for Patients With Lateral Hip Pain","3 Months Semi-supervised Exercise Intervention for Patients With Hip Abductor Tendon Pathology (HATP): A Prospective Clinical Cohort Study","Inclusion Criteria:\n\n* Age 18-75 years\n* MRI verified HATP\n* Lateral hip pain duration \\> 6 months\n* Ability to read and understand Danish.\n\nExclusion Criteria:\n\n* Corticosteroid injection in the affected hip joint within the last six weeks prior to the intervention\n* Previous bone-related surgery to the affected hip,\n* Signs of bilateral HATP\n* X-ray verified hip osteoarthritis\n* Pregnancy","75 Years",{"count":145,"type":22},[25],"This prospective cohort trial will investigate a progressive exercise protocol and patient education for patients with hip abductor tendon pathology. The primary outcome is patient reported pain measured by the revised Copenhagen Hip And Groin Outcome Score (HAGOS), that will be conducted at baseline and at a 12 week follow-up.",[175,28,176,177],"Gluteal Tendinitis","Hip and Thigh Injury","Rupture of Hip Abductor Tendon (Disorder)",[179,180,30,181],"Exercise","Patient education","Rehabilitation","2025-06-23",{"date":184,"type":39},"2025-06-26",{"date":186,"type":39},"2024-05-17",{"date":188,"type":22},"2027-02-01",{"name":190,"class":73},"Jeppe Lange",{"id":192,"slug":193,"hasResults":11,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":4,"eligibilityCriteria":197,"healthyVolunteers":11,"sex":17,"minAge":198,"maxAge":4,"enrollmentInfo":199,"targetDuration":4,"studyType":23,"phases":201,"briefSummary":202,"conditions":203,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":204,"lastUpdatePostDateStruct":205,"startDateStruct":207,"completionDateStruct":208,"leadSponsor":210,"locationsCount":74},"100551131","feasibility-of-a-home-exercise-program-with-the-addition-of-a-corticosteroid-injection-in-patients-with-lateral-hip-pain-100551131","NCT06456099","Feasibility of a Home Exercise Program With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain","Feasibility of a Home Exercise Program With the Addition of a Corticosteroid Injection in Patients With Greater Trochanteric Pain Syndrome in General Practice","Inclusion Criteria:\n\n* 35 years of age\n* Self-reported pain on the outside of the hip for at least 12 weeks with an average intensity of present pain over the last week of at least 4\u002F10 on a numeric rating scale 0-10 (0 being no hip pain and 10 being worst hip pain imaginable)\n* Access to a computer, smartphone or tablet with internet connection\n* Tenderness on palpation of the greater trochanter\n* Reproduction of lateral hip pain with 30 sec single leg stance test\n* Ability to speak and understand Danish (written and oral)\n* In case of bilateral hip pain, the study hip will be the most painful at inclusion\n\nExclusion Criteria:\n\n* Corticosteroid injection in the affected hip or other new treatment by a health professional within the last 3 months\n* History of systemic inflammatory diseases, e.g. rheumatoid arthritis, spondyloarthritis\n* Weekly intake of oral glucocorticoids\n* History of other hip conditions, e.g. clinically significant hip osteoarthritis, hip dysplasia, prior hip surgery\n* History of prior lumbar back surgery\n* Current low back pain or episodes of low back pain within the last 3 months that have caused sick leave and\u002For treatment by a health professional\n* Physical or mental disabilities that make it impossible to understand and\u002For perform exercises and complete questionnaires\n* Current or planned pregnancy or breastfeeding","35 Years",{"count":200,"type":22},20,[25],"We have developed an exercise protocol that we plan to evaluate in a future randomized controlled trial in combination with a corticosteroid injection. In accordance with the MRC Framework of Complex Interventions, which reccomends stepwise development of interventions and testing of feasibility before applying them to a trial, we aim to evaluate the feasibility of our intervention before initiating further trials.\n\nThe purpose of this non-randomized feasibility study is to test the feasibility and acceptability of this exercise protocol with addition of a corticosteroid injection with no aim of evaluating effects.\n\nAll participants in this study will receive the following interventions:\n\n* An ultrasound-guided corticosteroid injection superficial to the insertion of the gluteus medius and minimus tendons on the greater trochanter of the hip.\n* A home exercise program including 3 exercises, scalable to 3 different difficulty levels.\n* A patient information leaflet containing relevant information on managing lateral hip pain.",[28],"2024-06-07",{"date":206,"type":39},"2024-06-13",{"date":204,"type":39},{"date":209,"type":22},"2024-09-30",{"name":211,"class":73},"Aalborg University"]